PORTLAND, Maine, Jan. 09, 2023 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2022
PORTLAND, Maine, Nov. 21, 2022 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2022
Conference Call Scheduled for Tuesday, November 22, 2022 at 9:00 AM ETPORTLAND, Maine, Nov. 10, 2022 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and...
ImmuCell Corporation (ICCC) Company Webcast
ImmuCell Corporation's (Nasdaq: ICCC) purpose is to create scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle. ImmuCell manufactures and markets First Defense®, providing Immediate Immunity™ to newborn dairy...
ImmuCell to Participate in the Lytham Partners Fall 2022 Investor Conference
PORTLAND, Maine, Sept. 14, 2022 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2022
PORTLAND, Maine, Aug. 11, 2022 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2022
Conference Call Scheduled for Friday, August 12, 2022 at 9:00 AM ETPORTLAND, Maine, Aug. 04, 2022 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and...
ImmuCell Receives Technical Section Incomplete Letter from FDA Pertaining to Re-Tain®
PORTLAND, Maine, July 27, 2022 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Preliminary, Unaudited Sales Results for Second Quarter of 2022
PORTLAND, Maine, July 07, 2022 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Corp. (ICCC) Fireside Chat
Today, we welcome ImmuCell Corporation, which trades on the NASDAQ under the ticker, ICCC. We'll be engaging today with Michael Brigham, CEO of ImmuCell and a number of his sales team members in a discussion to give you a sense of the traction and the momentum they're...